行情

SNN

SNN

施乐辉
NYSE

实时行情|Nasdaq Last Sale

42.26
-0.05
-0.12%
已收盘, 16:11 11/12 EST
开盘
42.26
昨收
42.31
最高
42.45
最低
42.10
成交量
62.26万
成交额
--
52周最高
48.93
52周最低
35.39
市值
184.81亿
市盈率(TTM)
26.51
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

SNN 新闻

  • Bernstein Initiates Coverage On Smith & Nephew with Outperform Rating
  • Benzinga.1天前
  • Why Shares of Smith & Nephew Fell 10.2% in October
  • MotleyFool.com.1天前
  • Smith+Nephew launches industry-first OR3O™ Dual Mobility System utilising unique OXINIUM™ DH metal alloy for use in primary and revision hip arthroplasty
  • PR Newswire.5天前
  • How Much Of Smith & Nephew plc (LON:SN.) Do Institutions Own?
  • Simply Wall St..6天前

更多

所属板块

医疗设备、用品及经销
+0.68%
医疗设备和用品
+0.81%

热门股票

名称
价格
涨跌幅

SNN 简况

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices. The Sports Medicine Joint Repair franchise offers surgeons a range of instruments, technologies and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip and shoulder. The AET franchise offers an array of minimally invasive surgery-enabling systems and devices. The Trauma & Extremities franchise supports healthcare professionals with solutions used by surgeons to stabilize severe fractures, correct bone deformities, treat arthritis and heal soft tissue complications.
展开

Webull提供Smith & Nephew plc (ADR)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。